GENEVA, Jan. 28 -- SANEGENE BIO USA INC. (300 Tradecenter Dr, Suite 5500, Woburn, MA01801) filed a patent application (PCT/CN2025/109271) for "SMALL INTERFERING RNA TARGETING FXI AND USES THEREOF" on Jul 18, 2025. With publication no. WO/2026/017140, the details related to the patent application was published on Jan 22, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ZHOU, Chunxue (c/o Suzhou Sanegene Bio Inc., Room 301, Building B2, Phase III BioBAY, 99 Jingu RdSuzhou, Jiangsu 215103), SUN, Xiaowei (c/o Suzhou Sanegene Bio Inc., Room 301, Building B2, Phase III BioBAY, 99 Jingu RdSuzhou, Ji...